For pharmacies competing with CVS and relying on Caremark to serve patients, the prospect of those businesses operating under separate ownership is significant.
|Expert Interviews|August 6, 2018
AmerisourceBergen and Good Neighbor Pharmacy Invest in Programs and Resources to Help Community Pharmacies Succeed Now & in the Future
Advertisement
Brian Nightengale, President of Good Neighbor Pharmacy, discusses the tools and training available to help independent pharmacies align with the shifts in reimbursement and patient expectations.
Advertisement
Related to this article
Erin Albert of Mark Cuban Cost Plus Drugs explains how the Team Cuban Card offers transparent pricing and fair pay for independent pharmacies.
An abstract from the American Heart Association's Scientific Sessions 2026 reveals the continuous expansion of the GLP-1 medication class.
Matthew Crawford, PhD, of the University of Virginia, and Mario Danek of Qnovia explain what pharmacists can do now and what may come next.
The inquiry puts audit practices, including how pharmacies are selected for audit, proportionality, and pharmacy advocacy in focus.
Nolla Derm’s overseeing physician, Zaid Fadul, MD, FS, FAAFP, discusses the revolutionary AI technology that could transform how health care conducts prescribing practices.
As COVID-19 vaccine guidance shifts, new data suggest vaccinated patients face no greater clot or death risk than with other respiratory infections.
Alyssa Eisenberg, PharmD, explores technology’s emerging role in the health care environment and how the pharmacist of the future’s day-to-day tasks might evolve.
Advertisement
Advertisement
Trending on Drug Topics
1
PBM Audit Practices Under Scrutiny: What the House Inquiry Means for Independent Pharmacies
2
GLP-1s Outperform Metformin in Prediabetes Risk, MACE
3
CVS Plans to Split Off Its Retail Pharmacies, Keeping Specialty Operations
4
The Uncounted Threat: Antibiotic-Resistant Pneumonia
5